PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp2
|
ENSMUSG00000029563.17 | Foxp2 |
Foxp3
|
ENSMUSG00000039521.14 | Foxp3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp2 | mm39_v1_chr6_+_14901343_14901363 | -0.24 | 4.3e-02 | Click! |
Foxp3 | mm39_v1_chrX_+_7446721_7446732 | -0.24 | 4.7e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_171052623 | 24.45 |
ENSMUST00000111321.8
ENSMUST00000005824.12 ENSMUST00000111320.8 ENSMUST00000111319.2 |
Apoa2
|
apolipoprotein A-II |
chr4_+_104623505 | 22.69 |
ENSMUST00000031663.10
ENSMUST00000065072.7 |
C8b
|
complement component 8, beta polypeptide |
chr11_+_108286114 | 22.06 |
ENSMUST00000000049.6
|
Apoh
|
apolipoprotein H |
chr15_-_78352801 | 16.85 |
ENSMUST00000229124.2
ENSMUST00000230226.2 ENSMUST00000017086.5 |
Tmprss6
|
transmembrane serine protease 6 |
chr11_+_69945157 | 13.96 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr11_+_69983459 | 13.56 |
ENSMUST00000102572.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr11_+_69983479 | 12.45 |
ENSMUST00000143772.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr2_-_134396268 | 12.21 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr11_+_78389913 | 12.15 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chr11_+_69983531 | 12.01 |
ENSMUST00000124721.2
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr5_+_90608751 | 11.90 |
ENSMUST00000031314.10
|
Alb
|
albumin |
chr6_+_121323577 | 11.80 |
ENSMUST00000032200.16
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr5_-_145816774 | 11.26 |
ENSMUST00000035918.8
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr19_+_31846154 | 11.22 |
ENSMUST00000224564.2
ENSMUST00000224304.2 ENSMUST00000075838.8 ENSMUST00000224400.2 |
A1cf
|
APOBEC1 complementation factor |
chrX_+_100419965 | 11.21 |
ENSMUST00000119080.8
|
Gjb1
|
gap junction protein, beta 1 |
chr5_+_90708962 | 11.04 |
ENSMUST00000094615.8
ENSMUST00000200765.2 |
Albfm1
|
albumin superfamily member 1 |
chr10_+_93324624 | 10.93 |
ENSMUST00000129421.8
|
Hal
|
histidine ammonia lyase |
chr19_+_30210320 | 10.53 |
ENSMUST00000025797.7
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr12_-_103871146 | 10.38 |
ENSMUST00000074051.6
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr16_+_22710785 | 10.31 |
ENSMUST00000023583.7
ENSMUST00000232098.2 |
Ahsg
|
alpha-2-HS-glycoprotein |
chr8_-_122671588 | 10.05 |
ENSMUST00000057653.8
|
Car5a
|
carbonic anhydrase 5a, mitochondrial |
chr9_-_44714263 | 10.00 |
ENSMUST00000044694.8
|
Ttc36
|
tetratricopeptide repeat domain 36 |
chr12_-_103923145 | 9.85 |
ENSMUST00000085054.5
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr1_-_130589349 | 9.73 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr1_-_130589321 | 9.65 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr19_-_43974990 | 9.47 |
ENSMUST00000026210.5
|
Cpn1
|
carboxypeptidase N, polypeptide 1 |
chr6_+_116627567 | 9.39 |
ENSMUST00000067354.10
ENSMUST00000178241.4 |
Depp1
|
DEPP1 autophagy regulator |
chr1_-_184543367 | 9.30 |
ENSMUST00000048462.13
ENSMUST00000110992.9 |
Mtarc1
|
mitochondrial amidoxime reducing component 1 |
chr12_-_103623418 | 9.11 |
ENSMUST00000044159.7
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr19_-_34856853 | 9.11 |
ENSMUST00000036584.13
|
Pank1
|
pantothenate kinase 1 |
chr4_-_104733580 | 9.00 |
ENSMUST00000064873.9
ENSMUST00000106808.10 ENSMUST00000048947.15 |
C8a
|
complement component 8, alpha polypeptide |
chr2_-_110136074 | 8.75 |
ENSMUST00000046233.9
|
Bbox1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
chr12_-_81014849 | 8.64 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr3_+_146302832 | 8.47 |
ENSMUST00000029837.14
ENSMUST00000147409.2 ENSMUST00000121133.2 |
Uox
|
urate oxidase |
chr14_-_52150804 | 8.39 |
ENSMUST00000004673.15
ENSMUST00000111632.5 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr14_-_52151537 | 7.89 |
ENSMUST00000227402.2
ENSMUST00000227237.2 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr9_+_46179899 | 7.83 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr16_+_17149235 | 7.72 |
ENSMUST00000023450.15
ENSMUST00000231884.2 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr7_+_140343652 | 7.69 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr12_-_81014755 | 7.56 |
ENSMUST00000218342.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr2_+_58645189 | 7.52 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr15_+_54274151 | 7.42 |
ENSMUST00000036737.4
|
Colec10
|
collectin sub-family member 10 |
chr1_+_88334678 | 7.37 |
ENSMUST00000027518.12
|
Spp2
|
secreted phosphoprotein 2 |
chr14_-_52151026 | 7.35 |
ENSMUST00000228164.2
|
Ndrg2
|
N-myc downstream regulated gene 2 |
chr19_+_29078765 | 7.26 |
ENSMUST00000064393.6
ENSMUST00000235900.2 |
Rcl1
|
RNA terminal phosphate cyclase-like 1 |
chr5_-_87572060 | 7.08 |
ENSMUST00000072818.6
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr10_-_89369432 | 6.99 |
ENSMUST00000105297.2
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr5_-_87716882 | 6.77 |
ENSMUST00000113314.3
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr19_-_38113696 | 6.71 |
ENSMUST00000025951.14
ENSMUST00000237287.2 |
Rbp4
|
retinol binding protein 4, plasma |
chr11_+_114741948 | 6.70 |
ENSMUST00000133245.2
ENSMUST00000122967.3 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr5_-_87402659 | 6.69 |
ENSMUST00000075858.4
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr14_-_66246652 | 6.69 |
ENSMUST00000059970.9
|
Gulo
|
gulonolactone (L-) oxidase |
chr15_-_96947963 | 6.55 |
ENSMUST00000230907.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr6_+_116627635 | 6.33 |
ENSMUST00000204555.2
|
Depp1
|
DEPP1 autophagy regulator |
chr2_+_58644922 | 6.27 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr4_-_19922599 | 6.22 |
ENSMUST00000029900.6
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr5_-_145406533 | 6.00 |
ENSMUST00000031633.5
|
Cyp3a16
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
chr18_-_32271224 | 5.96 |
ENSMUST00000234657.2
ENSMUST00000234386.2 ENSMUST00000234651.2 |
Proc
|
protein C |
chr11_+_70104929 | 5.79 |
ENSMUST00000094055.10
ENSMUST00000126296.8 ENSMUST00000136328.2 ENSMUST00000153993.3 |
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr14_+_33662976 | 5.74 |
ENSMUST00000100720.2
|
Gdf2
|
growth differentiation factor 2 |
chr4_-_49549489 | 5.70 |
ENSMUST00000029987.10
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr15_-_39720855 | 5.56 |
ENSMUST00000022915.11
ENSMUST00000110306.9 |
Dpys
|
dihydropyrimidinase |
chr1_+_172525613 | 5.54 |
ENSMUST00000038495.5
|
Crp
|
C-reactive protein, pentraxin-related |
chr15_+_3300249 | 5.43 |
ENSMUST00000082424.12
ENSMUST00000159158.9 ENSMUST00000159216.10 ENSMUST00000160311.3 |
Selenop
|
selenoprotein P |
chr11_-_53313950 | 5.28 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr15_-_96918203 | 5.25 |
ENSMUST00000166223.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr14_-_31362835 | 5.15 |
ENSMUST00000167066.8
ENSMUST00000127204.9 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr6_+_87405968 | 5.13 |
ENSMUST00000032125.7
|
Bmp10
|
bone morphogenetic protein 10 |
chr9_+_46139878 | 5.07 |
ENSMUST00000034588.9
ENSMUST00000132155.2 |
Apoa1
|
apolipoprotein A-I |
chr15_-_96917804 | 5.00 |
ENSMUST00000231039.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr9_-_103107460 | 4.87 |
ENSMUST00000165296.8
ENSMUST00000112645.8 |
Trf
|
transferrin |
chr17_+_25097199 | 4.85 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr6_-_83633064 | 4.81 |
ENSMUST00000014686.3
|
Clec4f
|
C-type lectin domain family 4, member f |
chr1_-_180023518 | 4.77 |
ENSMUST00000162769.8
ENSMUST00000161379.2 ENSMUST00000027766.13 ENSMUST00000161814.8 |
Coq8a
|
coenzyme Q8A |
chr9_-_103107495 | 4.69 |
ENSMUST00000035158.16
|
Trf
|
transferrin |
chr6_-_23132977 | 4.68 |
ENSMUST00000031707.14
|
Aass
|
aminoadipate-semialdehyde synthase |
chrX_+_100420873 | 4.67 |
ENSMUST00000052130.14
|
Gjb1
|
gap junction protein, beta 1 |
chr1_+_67162176 | 4.65 |
ENSMUST00000027144.8
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr4_+_144619696 | 4.64 |
ENSMUST00000142808.8
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr15_+_99291100 | 4.61 |
ENSMUST00000159209.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr1_-_180023467 | 4.58 |
ENSMUST00000161746.2
ENSMUST00000160879.7 |
Coq8a
|
coenzyme Q8A |
chr4_+_138181616 | 4.50 |
ENSMUST00000050918.4
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr10_+_87695352 | 4.49 |
ENSMUST00000121952.8
ENSMUST00000126490.8 |
Igf1
|
insulin-like growth factor 1 |
chr1_+_9618173 | 4.42 |
ENSMUST00000144177.8
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1 |
chr12_+_8062331 | 4.40 |
ENSMUST00000171239.2
|
Apob
|
apolipoprotein B |
chr3_+_107137924 | 4.35 |
ENSMUST00000179399.3
|
A630076J17Rik
|
RIKEN cDNA A630076J17 gene |
chr14_-_31362909 | 4.26 |
ENSMUST00000022437.16
|
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr15_-_96929086 | 4.25 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr15_+_99290832 | 4.25 |
ENSMUST00000160635.8
ENSMUST00000161250.8 ENSMUST00000229392.2 ENSMUST00000161778.8 |
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr10_-_86843878 | 4.18 |
ENSMUST00000035288.17
|
Stab2
|
stabilin 2 |
chr14_+_55797934 | 4.17 |
ENSMUST00000121622.8
ENSMUST00000143431.2 ENSMUST00000150481.8 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr5_+_139375540 | 4.16 |
ENSMUST00000100514.3
|
Gpr146
|
G protein-coupled receptor 146 |
chr4_+_144619397 | 4.16 |
ENSMUST00000105744.8
ENSMUST00000171001.8 |
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr4_-_6275629 | 4.15 |
ENSMUST00000029905.2
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr17_-_12894716 | 4.11 |
ENSMUST00000024596.10
|
Slc22a1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr19_+_46611826 | 4.05 |
ENSMUST00000111855.5
|
Wbp1l
|
WW domain binding protein 1 like |
chr11_+_70104736 | 4.05 |
ENSMUST00000171032.8
|
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr19_-_58443830 | 4.01 |
ENSMUST00000026076.14
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr4_+_144619647 | 4.01 |
ENSMUST00000154208.8
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr12_-_84497718 | 4.00 |
ENSMUST00000085192.7
ENSMUST00000220491.2 |
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr17_+_25059079 | 3.99 |
ENSMUST00000164251.8
|
Hagh
|
hydroxyacyl glutathione hydrolase |
chr14_+_55798362 | 3.99 |
ENSMUST00000072530.11
ENSMUST00000128490.9 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr3_-_102871440 | 3.98 |
ENSMUST00000058899.13
|
Nr1h5
|
nuclear receptor subfamily 1, group H, member 5 |
chr19_-_58443593 | 3.96 |
ENSMUST00000135730.2
ENSMUST00000152507.8 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr8_-_45715049 | 3.85 |
ENSMUST00000034064.5
|
F11
|
coagulation factor XI |
chr6_+_134807170 | 3.83 |
ENSMUST00000111937.2
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr19_-_34855278 | 3.77 |
ENSMUST00000112460.3
|
Pank1
|
pantothenate kinase 1 |
chrX_+_138701544 | 3.77 |
ENSMUST00000054889.4
|
Cldn2
|
claudin 2 |
chr18_+_36797113 | 3.76 |
ENSMUST00000036765.8
|
Eif4ebp3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr7_-_80052491 | 3.74 |
ENSMUST00000122232.8
|
Furin
|
furin (paired basic amino acid cleaving enzyme) |
chr5_-_147259245 | 3.64 |
ENSMUST00000100433.5
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
chr10_-_25412010 | 3.61 |
ENSMUST00000179685.3
|
Smlr1
|
small leucine-rich protein 1 |
chr3_+_20011201 | 3.56 |
ENSMUST00000091309.12
ENSMUST00000108329.8 ENSMUST00000003714.13 |
Cp
|
ceruloplasmin |
chr4_+_133280680 | 3.52 |
ENSMUST00000042706.3
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr7_+_141056305 | 3.47 |
ENSMUST00000117634.2
|
Tspan4
|
tetraspanin 4 |
chr11_+_114742619 | 3.47 |
ENSMUST00000053361.12
ENSMUST00000021071.14 ENSMUST00000136785.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr7_+_100966289 | 3.46 |
ENSMUST00000163799.9
ENSMUST00000164479.9 |
Stard10
|
START domain containing 10 |
chr10_+_127734384 | 3.45 |
ENSMUST00000047134.8
|
Sdr9c7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
chr6_+_134807097 | 3.38 |
ENSMUST00000046303.12
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr14_+_55798517 | 3.35 |
ENSMUST00000117701.8
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr19_-_34855242 | 3.33 |
ENSMUST00000238065.2
|
Pank1
|
pantothenate kinase 1 |
chrX_-_7547273 | 3.29 |
ENSMUST00000115695.4
|
Magix
|
MAGI family member, X-linked |
chr4_+_148686985 | 3.25 |
ENSMUST00000105701.9
ENSMUST00000052060.7 |
Masp2
|
mannan-binding lectin serine peptidase 2 |
chr3_+_20011251 | 3.17 |
ENSMUST00000108328.8
|
Cp
|
ceruloplasmin |
chr3_+_20011405 | 3.16 |
ENSMUST00000108325.9
|
Cp
|
ceruloplasmin |
chr15_+_102875229 | 3.12 |
ENSMUST00000001699.8
|
Hoxc10
|
homeobox C10 |
chr6_-_52617288 | 3.07 |
ENSMUST00000031788.9
|
Hibadh
|
3-hydroxyisobutyrate dehydrogenase |
chr9_+_110162470 | 3.06 |
ENSMUST00000198761.5
ENSMUST00000197630.3 |
Scap
|
SREBF chaperone |
chr9_+_44951075 | 3.05 |
ENSMUST00000217097.2
|
Mpzl2
|
myelin protein zero-like 2 |
chr16_-_92196954 | 3.02 |
ENSMUST00000023672.10
|
Rcan1
|
regulator of calcineurin 1 |
chr13_+_81034214 | 3.01 |
ENSMUST00000161441.2
|
Arrdc3
|
arrestin domain containing 3 |
chr10_+_87696339 | 3.00 |
ENSMUST00000121161.8
|
Igf1
|
insulin-like growth factor 1 |
chr7_+_127400016 | 2.99 |
ENSMUST00000106271.2
ENSMUST00000138432.2 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr6_-_71417607 | 2.92 |
ENSMUST00000002292.15
|
Rmnd5a
|
required for meiotic nuclear division 5 homolog A |
chrX_-_137985960 | 2.90 |
ENSMUST00000033626.15
ENSMUST00000060824.4 |
Serpina7
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
chr10_-_67972401 | 2.89 |
ENSMUST00000218532.2
|
Arid5b
|
AT rich interactive domain 5B (MRF1-like) |
chr10_+_52267702 | 2.87 |
ENSMUST00000067085.7
|
Nepn
|
nephrocan |
chr5_-_87054796 | 2.86 |
ENSMUST00000031181.16
ENSMUST00000113333.2 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr4_+_34893772 | 2.85 |
ENSMUST00000029975.10
ENSMUST00000135871.8 ENSMUST00000108130.2 |
Cga
|
glycoprotein hormones, alpha subunit |
chr3_+_137923521 | 2.82 |
ENSMUST00000090171.7
|
Adh7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr3_-_146302343 | 2.81 |
ENSMUST00000029836.9
|
Dnase2b
|
deoxyribonuclease II beta |
chr12_-_83643964 | 2.77 |
ENSMUST00000048319.6
|
Zfyve1
|
zinc finger, FYVE domain containing 1 |
chr2_+_67948057 | 2.75 |
ENSMUST00000112346.3
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr18_+_51250748 | 2.71 |
ENSMUST00000116639.4
|
Prr16
|
proline rich 16 |
chr18_-_66155651 | 2.69 |
ENSMUST00000143990.2
|
Lman1
|
lectin, mannose-binding, 1 |
chr12_-_16696958 | 2.68 |
ENSMUST00000238839.2
|
Lpin1
|
lipin 1 |
chr12_-_69771604 | 2.68 |
ENSMUST00000021370.10
|
L2hgdh
|
L-2-hydroxyglutarate dehydrogenase |
chr19_-_46661321 | 2.64 |
ENSMUST00000026012.8
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr11_+_118913788 | 2.61 |
ENSMUST00000026662.8
|
Cbx2
|
chromobox 2 |
chr14_+_65595838 | 2.59 |
ENSMUST00000224623.2
|
Zfp395
|
zinc finger protein 395 |
chr11_-_43727071 | 2.57 |
ENSMUST00000167574.2
|
Adra1b
|
adrenergic receptor, alpha 1b |
chr12_+_76353835 | 2.54 |
ENSMUST00000220321.2
|
Mthfd1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase |
chr2_-_91025492 | 2.52 |
ENSMUST00000111354.2
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chr11_+_114742331 | 2.52 |
ENSMUST00000177952.8
|
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr8_-_33374282 | 2.51 |
ENSMUST00000209107.4
ENSMUST00000209022.3 |
Nrg1
|
neuregulin 1 |
chr18_-_39051695 | 2.50 |
ENSMUST00000040647.11
|
Fgf1
|
fibroblast growth factor 1 |
chr15_+_8997480 | 2.50 |
ENSMUST00000227191.3
|
Ranbp3l
|
RAN binding protein 3-like |
chr5_+_65505657 | 2.50 |
ENSMUST00000031096.11
|
Klb
|
klotho beta |
chr12_-_103623354 | 2.50 |
ENSMUST00000152517.2
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr12_-_83643883 | 2.49 |
ENSMUST00000221919.2
|
Zfyve1
|
zinc finger, FYVE domain containing 1 |
chr2_-_64806106 | 2.48 |
ENSMUST00000156765.2
|
Grb14
|
growth factor receptor bound protein 14 |
chr5_+_28370687 | 2.48 |
ENSMUST00000036177.9
|
En2
|
engrailed 2 |
chr10_-_95678786 | 2.48 |
ENSMUST00000211096.2
|
Gm33543
|
predicted gene, 33543 |
chr10_+_87695886 | 2.47 |
ENSMUST00000062862.13
|
Igf1
|
insulin-like growth factor 1 |
chr19_-_46661501 | 2.45 |
ENSMUST00000236174.2
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr10_+_85763545 | 2.43 |
ENSMUST00000170396.3
|
Ascl4
|
achaete-scute family bHLH transcription factor 4 |
chr3_+_5283577 | 2.42 |
ENSMUST00000175866.8
|
Zfhx4
|
zinc finger homeodomain 4 |
chr5_-_45607463 | 2.39 |
ENSMUST00000197946.5
ENSMUST00000127562.3 |
Qdpr
|
quinoid dihydropteridine reductase |
chr17_-_34846323 | 2.38 |
ENSMUST00000168709.3
ENSMUST00000064953.15 ENSMUST00000170345.8 ENSMUST00000171121.9 ENSMUST00000168391.9 ENSMUST00000169067.9 |
Gm20460
Ppt2
|
predicted gene 20460 palmitoyl-protein thioesterase 2 |
chr9_+_44309727 | 2.34 |
ENSMUST00000213268.2
|
Slc37a4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
chr3_+_5283606 | 2.29 |
ENSMUST00000026284.13
|
Zfhx4
|
zinc finger homeodomain 4 |
chr18_-_60881679 | 2.26 |
ENSMUST00000237783.2
|
Ndst1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr9_+_53212871 | 2.26 |
ENSMUST00000051014.2
|
Exph5
|
exophilin 5 |
chr11_+_114743044 | 2.25 |
ENSMUST00000142262.2
|
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr3_+_85946145 | 2.23 |
ENSMUST00000238331.2
|
Sh3d19
|
SH3 domain protein D19 |
chr2_+_4722956 | 2.21 |
ENSMUST00000056914.7
|
Bend7
|
BEN domain containing 7 |
chr3_+_94269745 | 2.21 |
ENSMUST00000169433.3
|
C2cd4d
|
C2 calcium-dependent domain containing 4D |
chr14_+_48358267 | 2.18 |
ENSMUST00000073150.6
|
Peli2
|
pellino 2 |
chrX_+_7588505 | 2.15 |
ENSMUST00000207675.2
ENSMUST00000116633.9 ENSMUST00000208996.2 ENSMUST00000144148.4 ENSMUST00000125991.9 ENSMUST00000148624.8 |
Wdr45
|
WD repeat domain 45 |
chr15_+_54434576 | 2.14 |
ENSMUST00000025356.4
|
Mal2
|
mal, T cell differentiation protein 2 |
chr8_-_49008305 | 2.13 |
ENSMUST00000110346.9
ENSMUST00000211976.2 |
Tenm3
|
teneurin transmembrane protein 3 |
chr10_-_95678748 | 2.13 |
ENSMUST00000210336.2
|
Gm33543
|
predicted gene, 33543 |
chr1_-_179373826 | 2.12 |
ENSMUST00000027769.6
|
Tfb2m
|
transcription factor B2, mitochondrial |
chr19_-_58444336 | 2.10 |
ENSMUST00000131877.2
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr4_+_134042423 | 2.09 |
ENSMUST00000105875.8
ENSMUST00000030638.7 |
Trim63
|
tripartite motif-containing 63 |
chr8_+_46080746 | 2.08 |
ENSMUST00000145458.9
ENSMUST00000134321.8 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr9_-_45866468 | 2.07 |
ENSMUST00000162072.8
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr6_+_53550349 | 2.06 |
ENSMUST00000203641.2
|
Creb5
|
cAMP responsive element binding protein 5 |
chr17_-_34846122 | 2.05 |
ENSMUST00000171376.8
ENSMUST00000169287.2 |
Ppt2
|
palmitoyl-protein thioesterase 2 |
chr15_+_9071655 | 2.04 |
ENSMUST00000227682.3
|
Nadk2
|
NAD kinase 2, mitochondrial |
chrX_+_7588453 | 2.04 |
ENSMUST00000043045.10
ENSMUST00000207386.2 ENSMUST00000116634.9 ENSMUST00000208072.2 ENSMUST00000207589.2 ENSMUST00000208618.2 ENSMUST00000208443.2 ENSMUST00000207541.2 ENSMUST00000208528.2 ENSMUST00000115689.10 ENSMUST00000131077.9 ENSMUST00000115688.8 ENSMUST00000208156.2 |
Wdr45
Gm45208
|
WD repeat domain 45 predicted gene 45208 |
chr5_-_115109118 | 2.02 |
ENSMUST00000031535.12
|
Hnf1a
|
HNF1 homeobox A |
chr15_+_9071331 | 2.00 |
ENSMUST00000190591.10
|
Nadk2
|
NAD kinase 2, mitochondrial |
chr1_-_138547403 | 1.99 |
ENSMUST00000027642.5
ENSMUST00000186017.7 |
Nek7
|
NIMA (never in mitosis gene a)-related expressed kinase 7 |
chr8_-_46747629 | 1.98 |
ENSMUST00000058636.9
|
Helt
|
helt bHLH transcription factor |
chr17_+_71511642 | 1.98 |
ENSMUST00000126681.8
|
Lpin2
|
lipin 2 |
chr15_+_99290763 | 1.97 |
ENSMUST00000023749.15
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr2_+_38401826 | 1.90 |
ENSMUST00000112895.8
|
Nek6
|
NIMA (never in mitosis gene a)-related expressed kinase 6 |
chr8_+_46080840 | 1.89 |
ENSMUST00000135336.9
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr15_-_53209513 | 1.86 |
ENSMUST00000077273.9
|
Ext1
|
exostosin glycosyltransferase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.3 | 37.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
4.0 | 11.9 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
3.9 | 23.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.2 | 9.5 | GO:0030070 | insulin processing(GO:0030070) |
3.1 | 21.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
2.8 | 11.2 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
2.8 | 22.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.4 | 9.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.2 | 8.8 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.2 | 10.9 | GO:0006548 | histidine catabolic process(GO:0006548) |
2.2 | 10.8 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
2.0 | 11.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.9 | 31.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.7 | 7.0 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
1.6 | 4.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.5 | 7.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.4 | 10.0 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.3 | 6.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.3 | 15.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.2 | 6.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.1 | 9.0 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
1.0 | 3.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
1.0 | 6.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.0 | 2.9 | GO:0033189 | response to vitamin A(GO:0033189) |
1.0 | 3.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.0 | 5.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.9 | 19.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.9 | 3.7 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.9 | 12.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.9 | 12.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.9 | 2.6 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.9 | 16.2 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.8 | 4.1 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.8 | 2.5 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.8 | 3.0 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.7 | 3.6 | GO:0010157 | response to chlorate(GO:0010157) |
0.7 | 2.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 2.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.7 | 2.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 5.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 4.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.7 | 5.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.7 | 4.6 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.7 | 6.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 | 20.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.6 | 12.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.6 | 2.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.6 | 2.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.6 | 2.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.6 | 5.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 1.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 19.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.6 | 1.8 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.6 | 1.8 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
0.6 | 1.7 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.6 | 1.7 | GO:0001966 | thigmotaxis(GO:0001966) |
0.5 | 1.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.5 | 1.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.5 | 3.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 7.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 2.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 4.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.3 | GO:0090650 | rRNA export from nucleus(GO:0006407) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.4 | 9.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 1.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 4.9 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 1.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 4.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 9.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.4 | 1.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 3.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 2.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 1.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 3.5 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.3 | 2.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 2.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 1.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.3 | 6.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 10.3 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.3 | 4.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.3 | 3.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 3.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 3.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 5.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 1.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 7.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 2.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 17.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 2.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 2.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 2.9 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 0.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 2.5 | GO:0061709 | reticulophagy(GO:0061709) |
0.3 | 0.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 1.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 9.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 4.8 | GO:0051132 | NK T cell activation(GO:0051132) |
0.3 | 2.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 2.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 2.9 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.3 | 3.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 38.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.2 | 4.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 1.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 2.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 1.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 1.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 6.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.4 | GO:1903487 | regulation of lactation(GO:1903487) |
0.2 | 2.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.6 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.2 | 2.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.6 | GO:0097273 | creatinine homeostasis(GO:0097273) cellular ammonia homeostasis(GO:0097275) cellular creatinine homeostasis(GO:0097276) cellular urea homeostasis(GO:0097277) |
0.2 | 0.8 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.6 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.2 | 0.8 | GO:0072233 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.2 | 1.2 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.2 | 4.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.8 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 1.2 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 1.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 2.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 3.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 2.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 1.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.2 | 1.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 1.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 0.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 3.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 2.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.6 | GO:0060807 | cardiogenic plate morphogenesis(GO:0003142) stem cell fate specification(GO:0048866) regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification(GO:0060807) endodermal digestive tract morphogenesis(GO:0061031) |
0.2 | 11.5 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 1.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 3.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 1.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:2000011 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
0.1 | 1.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 2.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 3.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 1.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 3.0 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 1.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.5 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 1.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.7 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 1.7 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.7 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 7.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.4 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 1.9 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 1.6 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 1.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 7.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.4 | GO:0000966 | pachytene(GO:0000239) RNA 5'-end processing(GO:0000966) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.6 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.1 | 0.4 | GO:0061188 | histone H4-K20 demethylation(GO:0035574) regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.3 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.1 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 12.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.4 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.1 | 0.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 1.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.5 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 10.9 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 2.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 2.0 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.6 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.2 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.1 | 3.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 1.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 2.2 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 19.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.6 | GO:2001269 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 6.3 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.3 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.1 | 1.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 1.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0061314 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) Notch signaling involved in heart development(GO:0061314) |
0.1 | 3.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.8 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.6 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 2.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 5.7 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 1.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 8.0 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
0.0 | 1.3 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 1.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 1.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 7.7 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 3.0 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 2.9 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.5 | GO:0002118 | aggressive behavior(GO:0002118) positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.4 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.6 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 1.3 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 2.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 3.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.0 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.5 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 1.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 2.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.4 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 2.4 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 30.0 | GO:0005579 | membrane attack complex(GO:0005579) |
2.8 | 63.8 | GO:0042627 | chylomicron(GO:0042627) |
1.6 | 10.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.5 | 14.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.4 | 11.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.3 | 13.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 5.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.9 | 9.9 | GO:0097433 | dense body(GO:0097433) |
0.9 | 5.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 3.3 | GO:0034657 | GID complex(GO:0034657) |
0.6 | 1.7 | GO:0043512 | inhibin A complex(GO:0043512) |
0.6 | 15.2 | GO:0005922 | connexon complex(GO:0005922) |
0.5 | 3.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 7.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 1.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.3 | 1.7 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 3.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.0 | GO:0044753 | amphisome(GO:0044753) |
0.3 | 1.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 12.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 4.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 4.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 2.4 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.9 | GO:1902737 | viral replication complex(GO:0019034) dendritic filopodium(GO:1902737) |
0.2 | 13.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 3.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.5 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.8 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 1.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 2.7 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 7.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 3.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 31.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 8.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 3.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 13.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 2.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 49.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 8.9 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 1.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 1.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 18.5 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 14.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.6 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 64.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 2.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 2.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 7.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 3.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 22.4 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 29.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
5.0 | 29.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.7 | 18.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
3.7 | 14.9 | GO:0005118 | sevenless binding(GO:0005118) |
2.7 | 16.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.4 | 7.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
2.3 | 13.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
2.2 | 6.7 | GO:0034632 | retinol transporter activity(GO:0034632) |
2.2 | 17.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
2.0 | 16.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.9 | 15.3 | GO:0005534 | galactose binding(GO:0005534) |
1.9 | 5.6 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
1.8 | 12.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.8 | 10.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.8 | 5.3 | GO:0005333 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
1.7 | 10.3 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
1.7 | 11.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.6 | 10.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.5 | 4.6 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
1.4 | 9.6 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
1.4 | 6.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.2 | 7.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.2 | 6.0 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.2 | 5.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.0 | 3.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.9 | 4.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.8 | 15.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.8 | 9.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.8 | 2.4 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.8 | 9.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.8 | 9.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 2.3 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.8 | 3.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.8 | 3.0 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.7 | 3.0 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.7 | 2.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.7 | 5.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.7 | 2.8 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.7 | 8.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.6 | 2.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 2.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.6 | 1.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 12.2 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 3.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 11.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 3.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.6 | 5.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 2.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.5 | 9.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 1.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.5 | 3.6 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.5 | 4.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 5.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.5 | 1.4 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.4 | 4.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 1.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 16.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.4 | 2.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.4 | 10.1 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 1.3 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 2.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.4 | 5.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.6 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 4.4 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 1.6 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.4 | 3.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 1.2 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.4 | 1.6 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.3 | 1.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 7.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 3.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 1.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 5.4 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 2.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 3.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 3.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 3.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 42.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 3.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 2.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 22.7 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.2 | 3.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 7.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 1.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 4.7 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 10.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 3.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 6.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 1.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 0.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 4.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 5.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 3.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 2.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 2.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 7.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 4.0 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 9.2 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 3.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.6 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.1 | 3.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.6 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 4.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 14.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 2.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 8.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.6 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 2.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 4.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 18.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 3.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 2.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 3.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 4.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 3.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 4.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 18.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 8.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.4 | GO:0017098 | CTP binding(GO:0002135) sulfonylurea receptor binding(GO:0017098) |
0.1 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 2.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 3.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 1.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 5.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 9.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 1.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.8 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 1.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 1.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 1.8 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 10.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 31.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 6.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 12.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 3.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 5.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 10.8 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 11.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 13.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 1.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 13.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 4.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 8.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 8.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 4.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 7.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.6 | 28.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.4 | 19.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.4 | 41.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.3 | 30.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.1 | 18.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.0 | 19.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 9.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 15.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.6 | 13.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.5 | 7.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.4 | 10.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 2.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 7.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.4 | 9.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 4.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 17.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 16.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 3.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 4.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 2.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 4.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 3.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 43.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 3.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 3.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 3.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 3.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 3.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 5.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 5.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 10.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 3.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 3.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 3.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 8.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 3.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 11.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 2.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |